Medicare Enrolled

Dr. Eddie Espanol, MD

Family Medicine · Tacoma, WA
Low-engagement
3124 S 19TH ST # 200, Tacoma, WA 98405
2534596166
In practice since 2010 (16 years)
NPI: 1497074314 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Espanol from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Espanol? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Espanol

Dr. Eddie Espanol is a family medicine specialist in Tacoma, WA, with 16 years of NPI registration.

Between the years covered by Open Payments, Dr. Espanol received a total of $2,523 from 29 pharmaceutical and/or device companies across 157 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Espanol is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice $2,523 industry payments

Industry Payment Transparency

Open Payments through 2022 ↗
$2,523
Total received (2018-2022)
Avg $631/year across 4 years
Top 8% in WA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
157
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,523 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$49
2020
$153
2019
$833
2018
$1,489

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$33
Janssen Pharmaceuticals, Inc
$16
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2018-2022) ›
Amgen Inc.
$260
PFIZER INC.
$253
Lilly USA, LLC
$230
Indivior Inc.
$223
Boehringer Ingelheim Pharmaceuticals, Inc.
$212
Novo Nordisk Inc
$187
Astellas Pharma US Inc
$126
Janssen Pharmaceuticals, Inc
$124
Takeda Pharmaceuticals U.S.A., Inc.
$115
Orexo US, Inc.
$109
GlaxoSmithKline, LLC.
$104
Merck Sharp & Dohme Corporation
$65
US WorldMeds, LLC
$64
Daiichi Sankyo Inc.
$59
SANOFI-AVENTIS U.S. LLC
$50
Bayer HealthCare Pharmaceuticals Inc.
$48
AstraZeneca Pharmaceuticals LP
$41
Shire North American Group Inc
$37
ABBVIE INC.
$33
Allergan Inc.
$29
Otsuka America Pharmaceutical, Inc.
$23
Neurocrine Biosciences, Inc.
$21
Amarin Pharma Inc.
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
Genentech USA, Inc.
$16
Gilead Sciences, Inc.
$16
Purdue Pharma L.P.
$14
AbbVie, Inc.
$14
Lupin Inc.
$12
Top 3 companies account for 29.5% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ANORO · Aimovig · Amitiza · BASAGLAR · BEXSERO · BREO · CHANTIX · Creon · EMGALITY · EVENITY · FARXIGA · GATTEX · INGREZZA · INJECTAFER · JARDIANCE · Kyleena · LINZESS · LYRICA · Lucemyra/Lofexidine · MYDAYIS · MYRBETRIQ · Morphabond ER · NEXPLANON · NUVARING · Ozempic · PREVNAR - 13 · PREVNAR 13 · Prolia · QULIPTA · ROTATEQ · Repatha · SHINGRIX · SOLIQUA · SOLOSEC · STIOLTO RESPIMAT · SUBLOCADE · Saxenda · TOUJEO · TRADJENTA · TRULICITY · Trintellix · VRAYLAR · Vascepa · Victoza · XARELTO · XIFAXAN · Xofluza · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for family medicine in WA.

Looking for a family medicine specialist in Tacoma?
Compare family medicine physicians in the Tacoma area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,241
Per 100K population
134.3
County median income
$96,632
Nearest hospital
ST JOSEPH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Espanol is a family medicine specialist, with low-engagement industry engagement in the top 8% of WA peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Espanol receive payments from pharmaceutical companies?
Yes. Dr. Espanol received a total of $2,523 from 29 companies across 157 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Espanol) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →